Umika 250 Injection
Marketer
Unigrow Pharmaceuticals
Salt Composition
Amikacin (250mg)
Overview Umika 250 Injection
Cefixime 250mg injection combats a broad spectrum of bacterial infections, encompassing urinary tract, bone, joint, lung (including pneumonia), brain, and bloodstream infections. Prophylactic use in hospitalized patients is also indicated. Its mechanism involves bacterial growth inhibition. Administered intravenously (drip) or intramuscularly by a healthcare professional only, it necessitates regular, evenly-spaced doses as directed. Complete the prescribed course; premature cessation risks relapse or infection exacerbation. Common adverse effects involve injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy warrant immediate medical consultation. High doses may exceptionally cause vertigo, nephrotoxicity, and ototoxicity. Strict adherence to physician instructions is crucial, including potential monitoring via kidney function, hearing, and urinalysis. Pregnancy contraindicates its use; disclose pregnancy, pregnancy intentions, or breastfeeding to your physician.
Primary Ingredients of Umika 250 Injection
No text provided to rephrase.
Uses of Umika 250 Injection
Infections caused by bacteria
Major Benefits of Umika 250 Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.
Common Side effects of Umika 250 Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Umika 250 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Umika 250 Injection works:
Umika 250 Injection is a bacterial growth inhibitor. Its antibiotic action arises from blocking the production of vital bacterial proteins, thereby disrupting essential cellular processes.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from using Umika 250 Injection concurrently with alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Umika 250 Injection during pregnancy is contraindicated due to confirmed risks to fetal development. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Administering Umika 250 Injection while breastfeeding presents minimal risk. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent danger to the infant.
DrivingUNSAFE
Administering Umika 250 Injection might reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCAUTION
Patients with kidney impairment should use Umika 250 Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Umika 250 Injection in individuals with liver impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary. However, physician consultation is recommended.
What if you forget to take Umika 250 Injection :
Should you forget a dose of Umika 250 Injection, seek your physician's advice.
Facts to Know About Umika 250 Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Behavior Class | Aminoglycoside antibiotics |
3,018 People bought this recently